Spots Global Cancer Trial Database for Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
Official Title: Pivotal Study for High Dose Therapy and Autologous Stem Cell Transplantation in Early Stages of CLL
Study ID: NCT00275015
Conditions
Study Description
Brief Summary: RATIONALE: Giving chemotherapy before a peripheral stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them. Giving colony-stimulating factors, such as G-CSF, and certain chemotherapy drugs, helps stem cells move from the bone marrow to the blood so they can be collected and stored. Chemotherapy or radiation therapy is then given to prepare the bone marrow for the stem cell transplant. The stem cells are then returned to the patient to replace the blood-forming cells that were destroyed by the chemotherapy and radiation therapy. PURPOSE: This phase II trial is studying how well giving cyclophosphamide together with total-body irradiation works in treating patients who are undergoing an peripheral stem cell transplant for chronic lymphocytic leukemia.
Detailed Description: OBJECTIVES: Primary * Determine the safety and feasibility of autologous peripheral blood stem cell transplantation in patients with chronic lymphocytic leukemia treated with cyclophosphamide and total-body irradiation. Secondary * Determine the safety, feasibility, and efficacy of combination therapy comprising dexamethasone, carmustine, cytarabine, etoposide, and melphalan (Dexa-BEAM) and filgrastim (G-CSF) mobilization in patients treated with this regimen. * Determine the efficacy of ex-vivo graft purging in patients treated with this regimen. * Determine the incidence of complete clinical and molecular remissions in patients treated with this regimen. * Determine the progression-free survival of patients treated with this regimen. OUTLINE: This is a multicenter, open-label, nonrandomized study. * Cytoreductive treatment: Patients undergo 2-4 courses of cytoreductive treatment, preferably following the fludarabine and cyclophosphamide (FC) protocol. * Stem cell mobilization: Patients achieving a complete remission (CR) or partial remission (PR) and stable blood counts undergo stem cell mobilization comprising dexamethasone, carmustine, cytarabine, etoposide, melphalan (Dexa-BEAM), and filgrastim (G-CSF). Patients with an adequate number of mobilized cells undergo stem cell collection. Patients with CR or very good PR proceed to myeloablative therapy. * Myeloablative therapy: Patients undergo total-body irradiation on day -4 and receive cyclophosphamide IV on days -4 and -3. * Autologous peripheral blood stem cell transplantation (PBSCT): Patients undergo autologous PBSCT on day 0. After completion of study, patients are followed periodically. PROJECTED ACCRUAL: A total of 150 patients will be accrued for this study.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hanuschkrankenhaus, Vienna, , Austria
Allg. Krankenhaus der Stadt Wien Universitaets-Kinderklinik, Wien, , Austria
Humaine - Clinic, Bad Saarow, , Germany
Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, , Germany
Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch, Berlin, , Germany
Universitaetsklinikum Bonn, Bonn, , Germany
Praxis Dres. F.& G. Doering, Bremen, , Germany
Universitatsklinikum Carl Gustav Carus, Dresden, , Germany
Universitaetsklinikum Duesseldorf, Duesseldorf, , Germany
Michael Schaefers und Partner, Duisburg, , Germany
Onkologische Schwerpunkt Praxis, Erlangen, , Germany
Universitaetsklinikum Essen, Essen, , Germany
Malteser Krankenhaus, Flensburg, , Germany
Gemeinschaftspraxis Fuer Innere Medizin, Hematologie Und Onkologie, Giessen, , Germany
Klinik Fuer Innere Medizin, Hematology/Oncology, Ernst Moritz Armdt Universitaet, Greifswald, , Germany
Universitätsklinikum Göttingen, Göttingen, , Germany
Asklepios Klinik St. Georg, Hamburg, , Germany
St. Marien-Hospital Hamm - Klinik Knappenstrasse, Hamm, , Germany
Krankenhaus Siloah - Medizinische Klinik II, Hannover, , Germany
Medizinische Hochschule Hannover, Hannover, , Germany
Universitaets-Kinderklinik Heidelberg, Heidelberg, , Germany
Universitatsklinikum Heidelberg, Heidelberg, , Germany
Universitaetsklinikum des Saarlandes, Homburg, , Germany
Klinikum der Friedrich-Schiller Universitaet Jena, Jena, , Germany
Westpfalz-Klinikum GmbH, Kaiserslautern, , Germany
Gemeinschaftspraxis fuer Haematologie, Onkologie und Infektiologie, Karlsruhe, , Germany
Internistische Gemeinschaftspraxis - Kassel, Kassel, , Germany
Staedtisches Krankenhaus Kiel, Kiel, , Germany
University Leipzig Clinic of Internal Medicine, Leipzig, , Germany
Universitaets - Kinderklinik - Luebeck, Lubeck, , Germany
Sana Kliniken Luebeck, Luebeck, , Germany
Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg, Magdeburg, , Germany
Universitatsklinik Mainz, Mainz, , Germany
Krankenhaus Maria Hilf GmbH, Moenchengladbach, , Germany
University of Muenster, Muenster, , Germany
Klinikum der Universitaet Muenchen - Innenstadt Campus, Munich, , Germany
Krankenhaus Muenchen Schwabing, Munich, , Germany
Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich, , Germany
Staedtisches Krankenhaus Muenchen - Harlaching, Munich, , Germany
Internistische Praxis - Neuss, Neuss, , Germany
Praxis fuer Haematologie und Interne Onkologie, Norderstedt, , Germany
Klinikum Nuernberg - Klinikum Nord, Nuernberg, , Germany
Internistische Gemeinschaftspraxis - Oldenburg, Oldenburg, , Germany
Klinikum Oldenburg, Oldenburg, , Germany
Klinikum Ernst Von Bergmann, Potsdam, , Germany
Klinik und Poliklinik fuer Innere Medizin - Universitaet Rostock, Rostock, , Germany
Diakonie Klinikum Stuttgart, Stuttgart, , Germany
Buergerhospital Stuttgart, Stuttgart, , Germany
Internistische Praxis - Trier, Trier, , Germany
Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm, Ulm, , Germany
Deutsche Klinik fuer Diagnostik, Wiesbaden, , Germany
Hamatologisch - Onkologische Praxis Wurzburg, Wurzburg, , Germany
University Wurzburg, Wurzburg, , Germany
Contact Details
Name: Peter Dreger
Affiliation: Universitaets-Kinderklinik Heidelberg
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
